Monday - March 23, 2026

Trauma Therapist Institute Announces April 8th Training: Introduction to Somatic EMDR – From Survival to Flourishing

DENVER, CO – The Trauma Therapist Institute© (TTI) invites EMDR-trained clinicians, counselors, and mental health professionals to attend a free virtual training designed to expand how trauma therapy addresses the body’s role in healing. Introduction to Somatic EMDR: From Survival to … Continue reading

Shop Genomics Launches Comprehensive Online Marketplace for Research-Grade Laboratory Equipment and Genomics Supplies

We recognized that the scientific community deserved the same streamlined purchasing experience that consumers enjoy in retail e-commerce. Shop Genomics bridges that gap by offering research-grade equipment through an intuitive platform that saves time and reduces procurement friction for laboratories … Continue reading

Diabetic Macular Edema Treatment Pipeline Shows Strong Momentum as 45+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Diabetic Macular Edema Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Diabetic Macular Edema pipeline landscape. It covers the Diabetic Macular Edema pipeline drug profiles, including clinical and nonclinical stage products. It … Continue reading

Diabetic Retinopathy Clinical Trial Pipeline Expands as 50+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Diabetic Retinopathy Pipeline Insights 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers the Diabetic Retinopathy pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading

Dry Eye Disease Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight

DelveInsight’s “Dry Eye Disease Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in the Dry Eye Disease pipeline landscape. It covers the Dry Eye Disease pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Cystic Fibrosis Clinical Trial Pipeline Accelerates as 75+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Cystic fibrosis Pipeline Insight, 2026” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Cystic fibrosis pipeline landscape. It covers the Cystic Fibrosis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading